# Daniel J. Hicklin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-j-hicklin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 53,181 |
| Field | Angiogenesis and VEGF in Cancer |
| h-index | 103 |
| i10-index | 175 |
| Last Known Institution | C4 Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5074599944 |
| ORCID iD | https://orcid.org/0009-0005-3474-9348 |
| Works | 349 |

## Researcher papers

- [Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose](https://scholariq.org/papers/cetuximab-induced-anaphylaxis-and-ige-specific-for-galactose-1-3-galactose/)
- [Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.](https://scholariq.org/papers/epidermal-growth-factor-receptor-blockade-with-c225-plus-gemcitabine-results-in/)

## Researcher topics

- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

## Researcher university

- [C4 Therapeutics (United States)](https://scholariq.org/institutions/c4-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.